Mitofusin2 decreases intracellular cholesterol of oxidized LDL-induced foam cells from rat vascular smooth muscle cells

Abstract

Mitofusin2 (Mfn2) plays a pivotal role in the proliferation and apoptosis of vascular smooth muscle cells (VSMCs). The purpose of this study was to investigate the effects of Mfn2 on the trafficking of intracellular cholesterol in the foam cells derived from rat VSMCs (rVSMCs) and also to investigate the effects of Mfn2 on the expression of adenosine triphosphate-binding cassette subfamily A member 1 (ABCA1), adenosine triphosphate-binding cassette subfamily G member 1 (ABCG1) and peroxisome proliferator-activated receptor gamma (PPARγ). The rVSMCs were co-cultured with oxidized low density lipoprotein (LDL, 80 μg/mL) to produce foam cells and cholesterol accumulation in cells. Before oxidized LDL treatment, different titers (20, 40 and 60 pfu/cell) of recombinant adenovirus containing Mfn2 gene (Adv-Mfn2) were added into the culture medium for 24 h to transfect the Mfn2 gene into the rVSMCs. Then the cells were harvested for analyses. The protein expression of Mfn2 was significantly higher in Adv-Mfn2-transfected group than in untransfected group (P<0.05), and the expression levels significantly increased when the titer of Adv-Mfn2 increased (P<0.05). At 24 or 48 h after oxidized LDL treatment, rVSMCs became irregular and their nuclei became larger, and their plasma abounded with red lipid droplets. However, the number of red lipid droplets was significantly decreased in Adv-Mfn2-transfected group as compared with untransfected group. At 48 h after oxidized LDL treatment, the intracellular cholesterol in rVSMCs was significantly increased (P<0.05), but it was significantly decreased in Adv-Mfn2-transfected group as compared with untransfected group (P<0.05), and it also significantly decreased when the titer of Adv-Mfn2 increased (P<0.05). The mRNA and protein expression levels of ABCA1 and ABCG1 were significantly increased in Adv-Mfn2-transfected group as compared with untransfected group (P<0.05). Though the mRNA and protein expression levels of PPARγ was not significantly increased (P>0.05), the phosporylation levels of PPARγ were significantly decreased in Adv-Mfn2-transfected group as compared with untransfected group (P<0.05). These results suggest that the transfection of Adv-Mfn2 can significantly reduce intracellular cholesterol in oxidized LDL-induced rVSMCs possibly by decreasing PPARγ phosporylation and then increasing protein expression levels of ABCA1 and ABCG1, which may be helpful to suppress the formation of foam cells.

Keywords

Mitofusin 2 / peroxisome proliferator-activated receptor gamma / adenosine triphosphate-binding cassette subfamily A member 1 / adenosine triphosphate-binding cassette subfamily G member 1 / vascular smooth muscle cells / oxidized low density lipoprotein / rats

References

[1] NakamuraR, OhtaT, IkedaY, et al.. LDL inhibits the mediation of cholesterol efflux from macrophage foam cells by apoA-I-containing lipoproteins. A putative mechanism for foam cell formation. Arterioscler Thromb, 1993, 13(9): 1307-1316

[2] Yvan-CharvetL, WangN, TallAR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol, 2010, 30(2): 139-143

[3] TangiralaRK, MahlbergFH, GlickJM, et al.. Lysosomal accumulation of unesterified cholesterol in model macrophage foam cells. J Biol Chem, 1993, 268(13): 9653-9660

[4] OgataM, TsujitaM, HossainMA, et al.. On the mechanism for PPAR agonists to enhance ABCA1 gene expression. Atherosclerosis, 2009, 205(2): 413-419

[5] JiangYJ, LuB, TarlingEJ, et al.. Regulation of ABCG1 expression in human keratinocytes and murine epidermis. J Lipid Res, 2010, 51(11): 3185-3195

[6] ChawlaA, BoisvertWA, LeeCH, et al.. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell, 2001, 7(1): 161-71

[7] AdamsM, ReginatoMJ, ShaoD, et al.. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J Biol Chem, 1997, 272(8): 5128-5132

[8] de BritoOM, ScorranoL. Mitofusin-2 regulates mitochondrial and endoplasmic reticulum morphology and tethering: the role of Ras. Mitochondrion, 2009, 9(3): 222-226

[9] ChenKH, GuoX, MaD, et al.. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol, 2004, 6(9): 872-883

[10] GuoYH, ChenK, GaoW, et al.. Overexpression of mitofusin 2 inhibited oxidized low-density lipoprotein induced vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit. Biochem Biophys Res Commun, 2007, 363(2): 411-417

[11] RudijantoA. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med Indones, 2007, 39(2): 86-93

[12] SchackelfordRE, MisraUK, Florine-CasteelK, et al.. Oxidized low density lipoprotein suppresses activation of NFkB in macrophages via a pertussis toxin-sensitive signaling mechanism. J Biol Chem, 1995, 270(8): 3475-3478

[13] ScottJ. The pathogenesis of atherosclerosis and new opportunities for treatment and prevention. J Neural Transm Suppl, 2002, 63: 1-17

[14] KohKK, HanSH, OhPC, et al.. Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction. Atherosclerosis, 2010, 209(2): 307-313

[15] AkiyamaTE, SakaiS, LambertG, et al.. Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol, 2002, 22(8): 2607-2619

[16] AyeIL, WaddellBJ, MarkPJ, et al.. Placental ABCA1 and ABCG1 transporters efflux cholesterol and protect trophoblasts from oxysterol induced toxicity. Biochim Biophys Acta, 2010, 1801(9): 1013-1024

[17] de BritoOM, ScorranoL. Mitofusin 2: a mitochondria shaping protein with signaling roles beyond fusion. Antioxid Redox Signal, 2008, 10(3): 621-633

[18] WermanA, HollenbergA, SolanesG, et al.. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPAR gamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin. J Biol Chem, 1997, 272(32): 20 230-20 235

[19] HsiLC, WilsonL, NixonJ, et al.. 15-lipoxygenase-1 metabolites down-regulate peroxisome proliferator-activated receptor gamma via the MAPK signaling pathway. J Biol Chem, 2001, 276(37): 34 545-34 552

[20] CampHS, TafuriSR. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J Biol Chem, 1997, 272(16): 10 811-10 816

[21] GuoX, ChenKH, GuoY, et al.. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res, 2007, 101(11): 1113-1122

[22] ChenKH, GuoX, MaD, et al.. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol, 2004, 6(9): 872-883

[23] SinghN, WebbR, AdamsR, et al.. The PPAR-gamma activator, Rosiglitazone, inhibits actin polymerisation in monocytes: involvement of Akt and intracellular calcium. Biochem Biophys Res Commun, 2005, 333(2): 455-462

[24] LiaoH, GongJ, ZhangW, et al.. Valsartan inhibits angiotensin II-induced proliferation of vascular smooth muscle cells via regulating the expression of mitofusin 2. J Huazhong Univ Sci Technol Med Sci, 2012, 32(1): 31-35

[25] KaplanJM, HakePW, DenenbergA, et al.. Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-gamma during polymicrobial sepsis. Mol Med, 2010, 16(11–12): 491-497

[26] OzasaH, AyaoriM, IizukaM, et al.. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARgamma/ LXRalpha pathway: findings from in vitro and ex vivo studies. Atherosclerosis, 2011, 219(1): 141-50